PRNP and Alzheimer disease: These data suggest that Aβ oligomer toxicity in AD may in fact be mediated by PrPC, and encourage further research focusing on protein-protein interaction inhibitors (PPII) to block the assembly of Aβ-PrPC aggregates in the treatment of AD.